Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry

医学 四分位间距 不良事件通用术语标准 危险系数 置信区间 内科学 比例危险模型 胃肠病学 队列 不利影响 实体瘤疗效评价标准 前瞻性队列研究 核医学 化疗 进行性疾病
作者
Taylor J. Robinson,Liping Du,Lea K. Matsuoka,Daniel Y. Sze,Andrew S. Kennedy,Ripal T Gandhi,Brian E. Kouri,Zachary S. Collins,Nima Kokabi,Christopher J. Grilli,Eric A. Wang,Justin S. Lee,Daniel B. Brown
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier BV]
卷期号:34 (4): 694-701.e3 被引量:23
标识
DOI:10.1016/j.jvir.2022.10.042
摘要

To report outcomes in patients with intrahepatic cholangiocarcinoma treated with yttrium-90 resin microspheres (transarterial radioembolization [TARE]) from a multicenter, prospective observational registry.Ninety-five patients (median age, 67 years [interquartile range {IQR}, 59-74]; 50 men) were treated in 27 centers between July 2015 and August 2020. Baseline demographic characteristics included imaging findings, performance status, and previous systemic or locoregional treatments. Dosimetry method was tracked. Overall survival (OS) and progression-free survival were calculated using the Kaplan-Meier method. The best imaging response was calculated using the Response Evaluation Criteria in Solid Tumors v1.1. Grade ≥3 toxicities were assessed using Common Terminology Criteria for Adverse Events v5. Cox regression analysis was performed.Fifty-two of 86 (60%) patients had multifocal tumors, and 24/89 (27%) had extrahepatic tumors. The median index tumor diameter was 7.0 cm (IQR, 4.9-10 cm). The activity calculation method was reported in 59/95 (62%) patients, with body surface area being the most frequently used method (45/59, 76%). Median OS for the cohort was 14 months (95% confidence interval, 12-22). OS at 3, 6, 12, and 24 months was 94%, 80%, 63%, and 34%, respectively. Median OS was longer in patients without cirrhosis (19.1 vs 12.2 months, P = .05). Cirrhosis, previous chemotherapy (OS, 19.1 vs 10.6 months for treatment-naïve; P = .07), and imaging response at 6 months (OS, 16.4 vs 9.5 months for no response; P = .06) underwent regression analysis. Imaging response predicted OS at regression (hazard ratio, 0.39; P = .008). Grade 3-4 bilirubin toxicities were noted in 5 of 72 (7%) patients. Grade 3 albumin toxicity was noted in 1 of 72 (1.4%) patients.Objective response at 6 months predicted longer OS after TARE for intrahepatic cholangiocarcinoma. The incidence of liver function toxicity was <10%.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑的应助被刻苦月亮采纳,获得10
1秒前
2秒前
整齐白秋完成签到 ,获得积分10
2秒前
Owen的应助被78j3采纳,获得10
2秒前
Ava的应助被姜昊彤采纳,获得10
2秒前
爆米花的应助被xxxx采纳,获得10
3秒前
肖坤完成签到 ,获得积分10
3秒前
3秒前
情怀的应助被科研通管家采纳,获得10
3秒前
xzy666的应助被科研通管家采纳,获得10
3秒前
斯文败类的应助被科研通管家采纳,获得10
3秒前
CAOHOU的应助被科研通管家采纳,获得10
3秒前
秋风的应助被科研通管家采纳,获得10
4秒前
说说发布了新的文献求助10
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
科研通AI65的应助被科研通管家采纳,获得10
4秒前
Youdge的应助被科研通管家采纳,获得10
4秒前
深情安青的应助被科研通管家采纳,获得10
4秒前
月白完成签到,获得积分10
4秒前
情怀的应助被科研通管家采纳,获得10
4秒前
ding的应助被科研通管家采纳,获得10
4秒前
归宁发布了新的文献求助10
5秒前
丘比特的应助被科研通管家采纳,获得10
5秒前
李爱国的应助被科研通管家采纳,获得10
5秒前
水弘的应助被科研通管家采纳,获得30
5秒前
5秒前
wanci的应助被科研通管家采纳,获得10
5秒前
CAOHOU的应助被科研通管家采纳,获得10
5秒前
5秒前
秋风的应助被科研通管家采纳,获得20
5秒前
5秒前
秋风的应助被科研通管家采纳,获得20
5秒前
5秒前
大模型的应助被yt采纳,获得10
5秒前
李健的应助被科研通管家采纳,获得10
6秒前
无花果的应助被wy采纳,获得10
6秒前
酷波er的应助被科研通管家采纳,获得10
6秒前
丁驰发布了新的文献求助10
6秒前
汉堡包的应助被sunfhz采纳,获得10
6秒前
计划明天炸地球完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192871
求助须知:如何正确求助?哪些是违规求助? 9579281
关于积分的说明 21864358
捐赠科研通 7792445
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483928